1162751008: Amivantamab (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\...

\Transferase inhibitor\Phosphotransferase inhibitor\Protein kinase inhibitor\...

\Epidermal growth factor receptor inhibitor\Amivantamab (substance)

\Protein-tyrosine kinase inhibitor\Mesenchymal epithelial transition inhibitor\Amivantamab (substance)

\Enzyme inhibitor protein\Amivantamab (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Antineoplastic agent (substance)\Mesenchymal epithelial transition inhibitor\Amivantamab (substance)
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Antineoplastic agent (substance)\Epidermal growth factor receptor inhibitor\Amivantamab (substance)
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Enzyme inhibitor protein\Amivantamab (substance)
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Monoclonal antibody\Amivantamab (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\...

\Enzyme inhibitor protein\Amivantamab (substance)

\Antibody\Monoclonal antibody\Amivantamab (substance)

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\...

\Enzyme inhibitor protein\Amivantamab (substance)

\Antibody\Monoclonal antibody\Amivantamab (substance)

\Biological substance\Protein and/or protein derivative\Protein\Enzyme inhibitor protein\Amivantamab (substance)
\Biological substance\Protein and/or protein derivative\Protein\Antibody\Monoclonal antibody\Amivantamab (substance)
\Biological substance\Immunologic substance\Antibody\Monoclonal antibody\Amivantamab (substance)
\Biological substance\Polypeptide\Protein\Enzyme inhibitor protein\Amivantamab (substance)
\Biological substance\Polypeptide\Protein\Antibody\Monoclonal antibody\Amivantamab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

4591202019 Amivantamab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

4591203012 Amivantamab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Amivantamab (substance)	Is a	Enzyme inhibitor protein	true	Inferred relationship	Some
Amivantamab (substance)	Is a	Monoclonal antibody	true	Inferred relationship	Some
Amivantamab (substance)	Is a	Mesenchymal epithelial transition inhibitor	true	Inferred relationship	Some
Amivantamab (substance)	Is a	Epidermal growth factor receptor inhibitor	true	Inferred relationship	Some
Amivantamab (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Mesenchymal epithelial transition inhibitor	true	Inferred relationship	Some
Amivantamab (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Epidermal growth factor receptor inhibitor	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Amivantamab-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Amivantamab (substance)	Inferred relationship	Some	1
Product containing only amivantamab (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Amivantamab (substance)	Inferred relationship	Some	1
Product containing only amivantamab in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Amivantamab (substance)	Inferred relationship	Some	1
Amivantamab-containing product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Amivantamab (substance)	Inferred relationship	Some	1

This concept is not in any reference sets